Elevance Health (NYSE: ELV) recently reported its Q3 results, with revenues exceeding but earnings missing the consensus estimates. The company reported revenue of $44.7 billion and adjusted earnings ...

Wondering whether Elevance Health at around US$374.71 is offering good value right now? This article walks through what the ...

Elevance Health (ELV) stock is back in focus after the company reported Q1 2026 results that surpassed revenue and adjusted ...

Investors in Elevance Health Inc (Symbol: ELV) saw new options begin trading today, for the January 2028 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, ...

Investors looking for stocks in the Medical Services sector might want to consider either Elevance Health (ELV) or GoodRx Holdings, Inc. (GDRX). But which of these two stocks offers value investors a ...

Elevance Health Inc. (NYSE:ELV) on Tuesday reported first-quarter 2025 revenues of $48.77 billion, up 15% year-over-year, higher than the consensus of $46.29 billion. The increase was driven by higher ...

Elevance Health Inc. (NYSE:ELV) shares plummeted nearly 12% on Thursday after the health insurer reported second-quarter 2025 adjusted earnings that missed analyst expectations and significantly ...

TheFly reported on April 20 that Jefferies analyst David Windley revised his outlook on ELV, trimming the firm’s price target ...

Artisan Partners, an investment management company, released its “Artisan Select Equity Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund’s Investor ...

CHONGQING, CHINA - JULY 13: In this photo illustration, a smartphone displaying the logo of Elevance Health, Inc. (NYSE: ELV), a major American health insurance provider and parent company of Anthem ...